Implementation and Operational Research: Declining Tuberculosis Incidence Among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012.

scientific article published on April 2016

Implementation and Operational Research: Declining Tuberculosis Incidence Among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/QAI.0000000000000896
P932PMC publication ID5902407
P698PubMed publication ID26910387

P50authorDenis NashQ60028944
Batya ElulQ62507275
Kara Wools-KaloustianQ83393653
Constantin T YiannoutsosQ83393956
P2093author name stringE Jane Carter
Lameck Diero
Suzue Saito
John Ssali
Philani Mpofu
Geoffrey R Somi
Simon Tsiouris
Musick S Beverly
P2860cites workGlobal, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Q21034169
Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001Q28469286
Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic reviewQ33302944
Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western KenyaQ33388709
Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic reviewQ33619740
Comparison of trends in tuberculosis incidence among adults living with HIV and adults without HIV--Kenya, 1998-2012Q33768889
Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?Q33795967
Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settingsQ33920318
Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South AfricaQ34196503
Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the communityQ34222186
The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, BrazilQ34717877
Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohortQ34717889
Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategiesQ35870509
Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan AfricaQ36301925
Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatmentQ36424963
Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South AfricaQ37240761
Drivers of tuberculosis epidemics: the role of risk factors and social determinantsQ37459996
A consistent log-linear relationship between tuberculosis incidence and body mass indexQ37612651
HIV infection-associated tuberculosis: the epidemiology and the responseQ37732313
Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART statusQ38453267
Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART.Q38459556
Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment studyQ38473741
Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resourcesQ42977188
The impact of antiretroviral treatment programs on tuberculosis notification ratesQ44648092
Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapyQ45734056
Successful integration of tuberculosis and HIV treatment in rural South Africa: the Sizonq'oba studyQ46260727
Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort studyQ46778392
Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohortQ46906005
Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infectionQ56344025
Integrating tuberculosis and HIV care in the primary care setting in South AfricaQ56559732
Effectiveness of cotrimoxazole prophylaxis on mortality in adults with tuberculosis in rural South AfricaQ59689434
Reduced tuberculosis case notification associated with scaling up antiretroviral treatment in rural MalawiQ62494420
HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease GroupQ64130054
Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA)Q71833584
Investigation of environmental and host-related risk factors for tuberculosis in Africa. I. Methodological aspects of a combined designQ74189905
The dynamics of tuberculosis in response to 10 years of intensive control effort in PeruQ74259159
P433issue4
P407language of work or nameEnglishQ1860
P921main subjecttuberculosisQ12204
East AfricaQ27407
P304page(s)e96-e106
P577publication date2016-04-01
P1433published inJournal of Acquired Immune Deficiency SyndromesQ6294722
P1476titleImplementation and Operational Research: Declining Tuberculosis Incidence Among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012.
P478volume71

Reverse relations

cites work (P2860)
Q36235752Association of Pulmonary Tuberculosis and HIV in the Mexican Institute of Social Security, 2006-2014.
Q91918132Decreased risk of HIV-associated TB during antiretroviral therapy expansion in rural Eswatini from 2009 to 2016: a cohort and population-based analysis
Q40060774Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care
Q39167835Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations
Q50041744Spatial overlap links seemingly unconnected genotype-matched TB cases in rural Uganda
Q59359915TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings

Search more.